Ann: Half Yearly Report and Accounts, page-14

Hi Mirthly,

Be careful what you said. You might get into trouble with a potential legal suit. I know some member here (not in this stock) got into trouble.

Things will not improve (less likely) each day with the share price falling backward to sub 6 cents. And the wost thing is we don't know if we have sufficient cash to last till FDA approval. Most likely not. If things have improved, why are we still generating few hundreds K in sales? Why the reimbursement is only $1.something million?

What happens to Chinese market? Zip sales? So that means all the costs and efforts gone wasted all these years since they now focus on US market. Again, the hospitals in Iran? Gone!

The European markets, fuxx all sales from these markets. You better hope and wish the US market works. If they don't, then we are stuffed! Look at LBT. The sp gone through the roof when the FDA approval took place and now, it gone straight back down.